Reconstructing formal logic: Further developments and considerations.
نویسندگان
چکیده
منابع مشابه
?Logic and Formal Ontology: Is the Final Formal Ontology Possible
Musa Akrami AbstractMany philosophers and logicians have contemplated the relationship between ontology and logic. The author of this paper, working within a Bolzanoan-Husserlian tradition of studying both ontology and logic, considers ontology as the science of the most general features of beings and the most general relations among them. He considers logic as the science concernin...
متن کاملReconstructing a formal security model
Role-based access control (RBAC) is a flexible approach to access control, which has generated great interest in the security community. The principal motivation behind RBAC is to simplify the complexity of administrative tasks. Several formal models of RBAC have been introduced. However, there are a few works specifying RBAC in a way which system developers or software engineers can easily und...
متن کاملFurther Considerations of Alienation
“Further Considerations of Alienation” attempts to expand upon an earlier essay entitled “Merleau-Ponty and a Reconsideration of Alienation.” From the point of view of Merleau-Ponty’s philosophy, this new essay considers modernist rationality and the postmodernist free play of language as forms of alienation. The essay attempts to show that Merleau-Ponty joins the company of Marx, Lukács, Haber...
متن کاملParasitic manipulation: further considerations.
“Is parasitic manipulation still a worthwhile research topic?” The answer, according to Thomas et al. (2005), is a resounding YES. A major reason for their confidence is the complexity of the topic, requiring significant input from field biologists, evolutionary biologists, experimentalists, neurobiologists and biochemists. Combining the different approaches, techniques, and backgrounds of such...
متن کاملTrastuzumab: Further Considerations
One of the best examples of the "bench to bedside" process is the development of trastuzumab (Herceptin) for HER2-overexpressed breast tumors. From the identification of the neu oncogene in 1984[1] and its subsequent cloning,[2] to the development of a humanized monoclonal antibody targeting HER2 that improved outcome not only in the metastatic setting[3] but also in the adjuvant setting[4-7] h...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Notre Dame Journal of Formal Logic
سال: 1970
ISSN: 0029-4527
DOI: 10.1305/ndjfl/1093893858